🇺🇸 FDA

Company profile · Sponsor

LENZ

LENZ Therapeutics

LENZ · NYSE biotech SOLANA BEACH, CA, USA
Pipeline
5
Drugs
1
Patents
8

Quick answer

LENZ (LENZ) is a biotech company. headquartered in SOLANA BEACH, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 1 drug, and 8 patents to this profile..

Company facts

Ticker LENZ
Exchange NYSE
Company type biotech
Headquarters SOLANA BEACH, CA, USA
SEC CIK 0001815776

Pipeline (5)

Search pipeline →

  1. Aceclidine+Brimonidine combination ophthalmic solution

    LENZ

    Presbyopia

    phase 3 small molecule completed

    6 trials

  2. Aceclidine+tropicamide combination

    LENZ

    Presbyopia

    phase 2 small molecule completed

    1 trial

  3. PRX-100

    LENZ

    Presbyopia

    phase 2 small molecule completed

    1 trial

  4. Aceclidine + Brimonidine

    LENZ

    Eye Diseases

    phase 1 small molecule completed

    1 trial

  5. LNZ101 (Aceclidine /Brimonidine) ophthalmic solution

    LENZ

    Presbyopia

    phase 1 small molecule completed

    1 trial

Drugs (1)

Search drugs →

  1. aceclidine hydrochloride

    VIZZ

    OPHTHALMIC approved

Patents (8)

Search patents →

  1. US 12414942

    Compositions, methods, and systems for treating presbyopia

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12180206

    Aceclidine derivatives, compositions thereof and methods of use thereof

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12128036

    Compositions and methods for storage stable ophthalmic drugs

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11648247

    Compositions and methods for the treatment of presbyopia

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11344538

    Methods for the treatment of myopia

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11273150

    Compositions and methods for the treatment of presbyopia

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11214569

    Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11179328

    Compositions and methods for the treatment of presbyopia

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is LENZ?

LENZ (LENZ) is a biotech company. headquartered in SOLANA BEACH, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 1 drug, and 8 patents to this profile..

What pipeline programs does LENZ sponsor?

We track 5 ClinicalTrials.gov-linked programs for LENZ, including Aceclidine+Brimonidine combination ophthalmic solution and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does LENZ company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.